Atara Biotherapeutics, Inc. (ATRA) Covered Calls
There are no covered calls available for Atara Biotherapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Atara Biotherapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company's product candidate includes PINTA 745, STM 434 and ATA 842. Atara Biotherapeutics was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Brisbane, CA.
| Top 10 Open Interest For Dec 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | SAVA covered calls | |
| 2. | SPY covered calls | 7. | XLF covered calls | 2. | HUT covered calls | |
| 3. | EEM covered calls | 8. | KWEB covered calls | 3. | CRVS covered calls | |
| 4. | FXI covered calls | 9. | TLT covered calls | 4. | ANAB covered calls | |
| 5. | IWM covered calls | 10. | AAPL covered calls | 5. | CLSK covered calls | |
Want more examples? ATR Covered Calls | ATRC Covered Calls
